Addressing the genetic aspect, in their study of six BTs associated with a mucinous tumor, Tafe et al. showed that four of the six tumor pairs showed KRAS hotspot driver mutations in the mucinous component [7]. The gene discussed is KRAS; the disease is mucinous neoplasm.